Research on Zebrafish Embryos Reveals Origin of the Lymphatic System
|
By LabMedica International staff writers Posted on 03 Jun 2015 |

Image: Zebrafish embryos with fluorescent blood vessels helped solve the mystery regarding the origin of the lymphatic system (Photo courtesy of the Weizmann Institute of Science).
A team of developmental biologists working with a zebrafish embryo model system has located the site of origin of the lymphatic system and identified a gene critical to the differentiation of stem cells into mature lymphatic cells.
Investigators at the Weizmann Institute of Science (Rehovot, Israel) exploited the transparent bodies of zebrafish embryos to document development in real time over a period of several days. By reversing the direction of the video images, they were able to determine that the cells giving rise to lymphatic vessels always originated in a niche of angioblasts localized at the same part of the embryo's major vein.
Zooming in to the molecular level, the investigators identified the Wnt5b protein as a novel lymphatic inductive signal in the zebrafish embryos and further showed that it promoted the "angioblast-to-lymphatic" transition in human embryonic stem cells as well. Wnt5b in humans is encoded by the WNT5B (Wingless-type MMTV integration site family, member 5B) gene. The WNT gene family consists of structurally related genes that encode secreted signaling proteins. These proteins have been implicated in oncogenesis and in several developmental processes, including regulation of cell fate and patterning during embryogenesis.
Writing in the May 20, 2015, online edition of the journal Nature, the investigators reported that addition of Wnt5b to cultures of human embryonic stem cells induced those cells to differentiate into lymphatic cells—possibly the first time such cells had been grown in a laboratory.
"We started out by imaging zebrafish, and ended up finding a factor that makes it possible to create lymphatic cells," said senior author Dr. Karina Yaniv, assistant professor of biological regulation at the Weizmann Institute of Science. "That is the beauty of research in developmental biology: The embryo holds the answers, and all we have to do is watch and learn."
Related Links:
Weizmann Institute of Science
Investigators at the Weizmann Institute of Science (Rehovot, Israel) exploited the transparent bodies of zebrafish embryos to document development in real time over a period of several days. By reversing the direction of the video images, they were able to determine that the cells giving rise to lymphatic vessels always originated in a niche of angioblasts localized at the same part of the embryo's major vein.
Zooming in to the molecular level, the investigators identified the Wnt5b protein as a novel lymphatic inductive signal in the zebrafish embryos and further showed that it promoted the "angioblast-to-lymphatic" transition in human embryonic stem cells as well. Wnt5b in humans is encoded by the WNT5B (Wingless-type MMTV integration site family, member 5B) gene. The WNT gene family consists of structurally related genes that encode secreted signaling proteins. These proteins have been implicated in oncogenesis and in several developmental processes, including regulation of cell fate and patterning during embryogenesis.
Writing in the May 20, 2015, online edition of the journal Nature, the investigators reported that addition of Wnt5b to cultures of human embryonic stem cells induced those cells to differentiate into lymphatic cells—possibly the first time such cells had been grown in a laboratory.
"We started out by imaging zebrafish, and ended up finding a factor that makes it possible to create lymphatic cells," said senior author Dr. Karina Yaniv, assistant professor of biological regulation at the Weizmann Institute of Science. "That is the beauty of research in developmental biology: The embryo holds the answers, and all we have to do is watch and learn."
Related Links:
Weizmann Institute of Science
Latest BioResearch News
- Disease Gene Discovery Advances Diagnosis of Rare Movement Disorders
- Genetic Discovery Could Improve Diagnosis of Drug-Resistant Epilepsy
- Genetic Discovery May Improve Diagnosis of Rare Dementia Subtype
- Mass Spectrometry Technique Detects Protein and Sugar Changes in Neurodegeneration
- Barcoded DNA Sheds Light on Hidden Complexities in Breast Cancer Detection
- CRISPR-Based Platform Pinpoints Drivers of Acute Myeloid Leukemia in Patient Cells
- Protective Brain Protein Emerges as Biomarker Target in Alzheimer’s Disease
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
Channels
Clinical Chemistry
view channel
New Plasma Tau Assay Improves Prediction of Alzheimer’s Progression
Predicting which patients with early symptomatic Alzheimer’s disease will decline more rapidly remains a key challenge in both research and patient care. Growing interest in tau biology, along with advances... Read more
Routine Blood Markers Predict Heart Failure Risk in Prediabetes
Heart failure prevention relies on finding high-risk adults before symptoms appear, yet effective stratification remains difficult in routine care. Prediabetes affects an estimated 115.2 million U.... Read moreMolecular Diagnostics
view channel
Blood Test Helps Guide Treatment in Older Women with Breast Cancer
Older women with estrogen receptor–positive breast cancer often face difficult decisions about treatment, especially when surgery and radiation can lead to side effects such as scarring, swelling, infection... Read more
Liquid Biopsy Method Pinpoints Disease Source From a Single Drop of Blood
Liquid biopsy offers a noninvasive way to assess disease, but many assays still lack reliable tissue-of-origin localization and robust performance for early cancer detection. Researchers now report a method... Read moreHematology
view channel
Rapid Cartridge-Based Test Aims to Expand Access to Hemoglobin Disorder Diagnosis
Sickle cell disease and beta thalassemia are hemoglobin disorders that often require referral to specialized laboratories for definitive diagnosis, delaying results for patients and clinicians.... Read more
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read moreImmunology
view channel
Cancer Mutation ‘Fingerprints’ to Improve Prediction of Immunotherapy Response
Cancer cells accumulate thousands of genetic mutations, but not all mutations affect tumors in the same way. Some make cancer cells more visible to the immune system, while others allow tumors to evade... Read more
Immune Signature Identified in Treatment-Resistant Myasthenia Gravis
Myasthenia gravis is a rare autoimmune disorder in which immune attack at the neuromuscular junction causes fluctuating weakness that can impair vision, movement, speech, swallowing, and breathing.... Read more
New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer
Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read moreBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read moreMicrobiology
view channel
Study Highlights Accuracy Gaps in Consumer Gut Microbiome Kits
Direct-to-consumer gut microbiome kits promise personalized insights by profiling fecal bacteria and generating health readouts, but their analytical accuracy remains uncertain. A new study shows that... Read more
WHO Recommends Near POC Tests, Tongue Swabs and Sputum Pooling for TB Diagnosis
Tuberculosis (TB) remains one of the world’s leading infectious disease killers, yet millions of cases go undiagnosed or are detected too late. Barriers such as reliance on sputum samples, limited laboratory... Read morePathology
view channel
AI-Powered Tool to Transform Dermatopathology Workflow
Skin cancer accounts for the largest number of cancer diagnoses in the United States, placing sustained pressure on pathology services. Diagnostic interpretation can be variable for challenging melanocytic... Read more
New Chromogenic Culture Media Enable Rapid Detection of Candida Infections
Invasive Candida infections are challenging for healthcare systems, with some strains spreading rapidly in hospitals and showing resistance to multiple antifungal drugs. Candida auris is associated with... Read moreTechnology
view channel
New Electronic Pipette Enhances Workflows with Touchscreen Control
Manual pipetting remains a routine yet error-prone step that can affect reproducibility and throughput in clinical and research laboratories. Training demands and ergonomic strain also add variability... Read more
AI Model Outperforms Clinicians in Rare Disease Detection
Rare diseases affect an estimated 300 million people worldwide, yet diagnosis is often protracted and error-prone. Many conditions present with heterogeneous signs that overlap with common disorders, leading... Read more
AI-Driven Diagnostic Demonstrates High Accuracy in Detecting Periprosthetic Joint Infection
Periprosthetic joint infection (PJI) is a rare but serious complication affecting 1% to 2% of primary joint replacement surgeries. The condition occurs when bacteria or fungi infect tissues around an implanted... Read moreIndustry
view channel
Automated MSI Test Gains IVDR Certification to Guide CRC Therapy
Treatment selection for metastatic colorectal cancer often requires knowledge of a tumor’s microsatellite instability (MSI) status. Timely results can help clinicians decide on immunotherapy options.... Read more








